These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 15603533)

  • 21. A clinical study of wintomylon in the treatment of shigellosis.
    Yu PC; Chen HS
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1965; 6(3):127-31. PubMed ID: 5861506
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of norfloxacin for shigellosis: a double-blind randomised clinical trial.
    Bhattacharya MK; Nair GB; Sen D; Paul M; Debnath A; Nag A; Dutta D; Dutta P; Pal SC; Bhattacharya SK
    J Diarrhoeal Dis Res; 1992 Sep; 10(3):146-50. PubMed ID: 1430968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of bacillary dysentery].
    Gioieni A
    Clin Ter; 1980 Jan; 92(2):197-80. PubMed ID: 7389276
    [No Abstract]   [Full Text] [Related]  

  • 24. Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern.
    Kansakar P; Malla S; Ghimire GR
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):32-7. PubMed ID: 18603983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid.
    De Mol P; Mets T; Lagasse R; Vandepitte J; Mutwewingabo A; Butzler JP
    J Antimicrob Chemother; 1987 May; 19(5):695-8. PubMed ID: 3301783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing antimicrobial resistance--an emerging problem in the treatment of shigellosis.
    Niyogi SK
    Clin Microbiol Infect; 2007 Dec; 13(12):1141-3. PubMed ID: 17953700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Magnitude of drug resistant Shigellosis: a report from Bangalore.
    Srinivasa H; Baijayanti M; Raksha Y
    Indian J Med Microbiol; 2009; 27(4):358-60. PubMed ID: 19736408
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative efficacy of furazolidone and nalidixic acid in the empirical treatment of acute invasive diarrhea: randomized clinical trial.
    Dutta P; Sett A; Sarkar A; Mitra U; Saha D; Manna B; Kundu B; Gupta A
    Indian Pediatr; 1995 Jan; 32(1):13-9. PubMed ID: 8617528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effectiveness of antibiotics in current treatment of dysentery].
    Bruckner S; Teodorescu G; Cotarcea S; Predescu I; Taindel C; Tesio C; Georgescu M; Burlacu G
    Pediatria (Bucur); 1971; 20(4):333-9. PubMed ID: 5096667
    [No Abstract]   [Full Text] [Related]  

  • 30. [Bacillary dysentery shigellosis].
    Matsushita S; Kawamura M
    Nihon Rinsho; 2007 Mar; 65 Suppl 3():74-7. PubMed ID: 17491367
    [No Abstract]   [Full Text] [Related]  

  • 31. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
    Salam MA; Dhar U; Khan WA; Bennish ML
    Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis.
    Haltalin KC; Nelson JD; Kusmiesz HT
    Arch Dis Child; 1973 Apr; 48(4):305-12. PubMed ID: 4574641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors for death in hospitalized dysentery patients in Rwanda.
    Legros D; Paquet C; Dorlencourt F; Saoult E
    Trop Med Int Health; 1999 Jun; 4(6):428-32. PubMed ID: 10444318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transferable multiple drug resistance in enterobacteria from non-human primates. I. Development and characteristics of resistance in Shigella Flexneri.
    Hardy PH; Lindsey JR; Melby EC
    Johns Hopkins Med J; 1968 Jul; 123(1):29-37. PubMed ID: 5667656
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of bacillary dysentery in Vietnamese children: two doses of ofloxacin versus 5-days nalidixic acid.
    Vinh H; Wain J; Chinh MT; Tam CT; Trang PT; Nga D; Echeverria P; Diep TS; White NJ; Parry CM
    Trans R Soc Trop Med Hyg; 2000; 94(3):323-6. PubMed ID: 10975012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple transmissible drug resistance in an outbreak of Shigella flexneri infection.
    Lewis MJ
    Lancet; 1967 Nov; 2(7523):953-6. PubMed ID: 4167515
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial susceptibilities of Shigella species isolated in Ontario in 1990.
    Harnett N
    Can Dis Wkly Rep; 1991 Dec; 17(50):275-7. PubMed ID: 1843660
    [No Abstract]   [Full Text] [Related]  

  • 38. Bacillary dysentery. An institutional outbreak of Shigella sonnei: treatment of 36 cases with nalidixic acid.
    Fernandez LA
    J Kans Med Soc; 1966 Jul; 67(7):359-60 passim. PubMed ID: 5330682
    [No Abstract]   [Full Text] [Related]  

  • 39. [Epidemiological and therapeutic considerations on 46 cases of shigellosis in childhood].
    Pitruzzella E; Raspone C; Pitruzzella D; Lo Iacono G
    Pediatria (Napoli); 1981; 89(2):219-33. PubMed ID: 7312491
    [No Abstract]   [Full Text] [Related]  

  • 40. [On the problem of treatment of shigelloses. I. Observation of sensitivity of isolated shigella strains and of the levels of various antibiotics in the blood and feces].
    Lonská V; Ondrácek J; Lisková M; Bastecká V
    Cesk Epidemiol Mikrobiol Imunol; 1967 Nov; 16(6):354-8. PubMed ID: 4229468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.